Global Information
회사소개 | 문의 | 비교리스트

세계의 애완동물용 암치료제 시장 : 치료, 투여 경로, 동물 유형, 용도별 - COVID-19의 영향, 지역적 전망, 용도 잠재성, 시장 점유율, 예측(2021-2027년)

Pet Cancer Therapeutics Market Size By Therapy, By Route of Administration, By Species, By Application, COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2021 - 2027

리서치사 Global Market Insights Inc.
발행일 2021년 12월 상품코드 1044819
페이지 정보 영문 120 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 5,150 ₩ 6,562,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 9,110,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 11,658,000 Printable PDF (Enterprise User License)


세계의 애완동물용 암치료제 시장 : 치료, 투여 경로, 동물 유형, 용도별 - COVID-19의 영향, 지역적 전망, 용도 잠재성, 시장 점유율, 예측(2021-2027년) Pet Cancer Therapeutics Market Size By Therapy, By Route of Administration, By Species, By Application, COVID-19 Impact Analysis, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2021 - 2027
발행일 : 2021년 12월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

애완동물용 암치료제 시장은 세계에서 애완동물 케어 지출의 증가에 의해 2027년까지 상당한 이익을 획득할 것으로 예측됩니다.

또한 애완동물 사이에서 암의 급증으로 인해 보다 종합적인 예측적 동물 모델의 필요성이 높아지고 있으며, 애완동물용 암치료제의 R&D 활동이 활발해지고 있습니다. 또한 애완동물의 질병 및 치료법에 대한 소유주의 의식이 높아지고 있는 것도 최근의 채택을 지원하고 있습니다.

치료법별로 보면 표적치료 부문이 2020년에 3,200만 달러 초과를 보이며, 예측 기간 중 안정된 페이스로 성장할 것으로 예상되고 있습니다. 이 치료법의 범용성과 암의 표적 치료 분야에서의 새로운 진보가 기간중의 성장을 지원할 것으로 생각되고 있습니다. 또한 투여 경로별로는 경구투여 부문이 2020년에 약 8,000만 달러 규모를 보이며, 앞으로도 견고한 성장이 전망됩니다. 이 성장은 경구투여에 의한 약제의 투여가 용이한 것에 기인하고 있습니다.

세계의 애완동물용 암치료제 시장을 조사했으며, 시장의 정의와 개요, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 법규제 환경, 제품 파이프라인의 동향, 시장 규모의 추이·예측, 치료·투여 경로·동물 유형·용도·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 조사 방법

제2장 개요

제3장 애완동물용 암치료제 산업 인사이트

  • 산업 세분화
  • 산업 상황
  • 산업의 영향요인
    • 성장요인
    • 잠재적 리스크 & 과제
  • 성장의 가능성
  • COVID-19 : 영향 분석
  • 제품 파이프라인 분석
  • 규제 상황
  • Porter의 산업 분석
  • 경쟁 구도
  • PESTEL 분석

제4장 애완동물용 암치료제 시장 : 치료별

  • 주요 동향
  • 화학요법
  • 면역치료
  • 표적치료
  • 병용요법

제5장 애완동물용 암치료제 시장 : 투여 경로별

  • 주요 동향
  • 경구
  • 주사

제6장 애완동물용 암치료제 시장 : 동물 유형별

  • 주요 동향
  • 고양이

제7장 애완동물용 암치료제 시장 : 용도별

  • 주요 동향
  • 림프종
  • 비만 세포암
  • 흑색종
  • 유선암 및 편평상피암
  • 기타

제8장 애완동물용 암치료제 시장 : 지역별

  • 주요 동향
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제9장 기업 개요

  • 경쟁 대시보드
  • Zoetis, Inc.
  • Elanco Animal Health
  • Merial, Inc.(Boehringer Ingelheim International GmbH)
  • Anivive Lifesciences, Inc.
  • AB Science
  • Qbiotics
  • NovaVive, Inc.
  • ELIAS Animal Health
KSA 22.01.20

Data Tables

  • TABLE 1. Pet cancer therapeutics industry 360 degree synopsis, 2016-2027
  • TABLE 2. Global pet cancer therapeutics market, 2016 - 2020 (USD Million)
  • TABLE 3. Global pet cancer therapeutics market, 2021 - 2027 (USD Million)
  • TABLE 4. Global pet cancer therapeutics market, by therapy, 2016 - 2020 (USD Million)
  • TABLE 5. Global pet cancer therapeutics market, by therapy, 2021 - 2027 (USD Million)
  • TABLE 6. Global pet cancer therapeutics market, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 7. Global pet cancer therapeutics market, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 8. Global pet cancer therapeutics market, by species, 2016 - 2020 (USD Million)
  • TABLE 9. Global pet cancer therapeutics market, by species, 2021 - 2027 (USD Million)
  • TABLE 10. Global pet cancer therapeutics market, by application, 2016 - 2020 (USD Million)
  • TABLE 11. Global pet cancer therapeutics market, by application, 2021 - 2027 (USD Million)
  • TABLE 12. Global pet cancer therapeutics market, by region, 2016 - 2020 (USD Million)
  • TABLE 13. Global pet cancer therapeutics market, by region, 2021 - 2027 (USD Million)
  • TABLE 14. Industry impact forces
  • TABLE 15. Chemotherapy market size, by region, 2016 - 2020 (USD Million)
  • TABLE 16. Chemotherapy market size, by region, 2021 - 2027 (USD Million)
  • TABLE 17. Immunotherapy market size, by region, 2016 - 2020 (USD Million)
  • TABLE 18. Immunotherapy market size, by region, 2021 - 2027 (USD Million)
  • TABLE 19. Targeted therapy market size, by region, 2016 - 2020 (USD Million)
  • TABLE 20. Targeted therapy market size, by region, 2021 - 2027 (USD Million)
  • TABLE 21. Combination therapy market size, by region, 2016 - 2020 (USD Million)
  • TABLE 22. Combination therapy market size, by region, 2021 - 2027 (USD Million)
  • TABLE 23. Oral market size, by region, 2016 - 2020 (USD Million)
  • TABLE 24. Oral market size, by region, 2021 - 2027 (USD Million)
  • TABLE 25. Injection market size, by region, 2016 - 2020 (USD Million)
  • TABLE 26. Injection market size, by region, 2021 - 2027 (USD Million)
  • TABLE 27. Dogs market size, by region, 2016 - 2020 (USD Million)
  • TABLE 28. Dogs market size, by region, 2021 - 2027 (USD Million)
  • TABLE 29. Cats market size, by region, 2016 - 2020 (USD Million)
  • TABLE 30. Cats market size, by region, 2021 - 2027 (USD Million)
  • TABLE 31. Lymphoma market size, by region, 2016 - 2020 (USD Million)
  • TABLE 32. Lymphoma market size, by region, 2021 - 2027 (USD Million)
  • TABLE 33. Mast cell tumor market size, by region, 2016 - 2020 (USD Million)
  • TABLE 34. Mast cell tumor market size, by region, 2021 - 2027 (USD Million)
  • TABLE 35. Melanoma market size, by region, 2016 - 2020 (USD Million)
  • TABLE 36. Melanoma market size, by region, 2021 - 2027 (USD Million)
  • TABLE 37. Mammary and squamous cell cancer market size, by region, 2016 - 2020 (USD Million)
  • TABLE 38. Mammary and squamous cell cancer market size, by region, 2021 - 2027 (USD Million)
  • TABLE 39. Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 40. Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 41. North America pet cancer therapeutics market size, by country, 2016 - 2020 (USD Million)
  • TABLE 42. North America pet cancer therapeutics market size, by country, 2021 - 2027 (USD Million)
  • TABLE 43. North America pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 44. North America pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 45. North America pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 46. North America pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 47. North America pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 48. North America pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 49. North America pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 50. North America pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 51. U.S. pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 52. U.S. pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 53. U.S. pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 54. U.S. pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 55. U.S. pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 56. U.S. pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 57. U.S. pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 58. U.S. pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 59. Canada pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 60. Canada pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 61. Canada pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 62. Canada pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 63. Canada pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 64. Canada pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 65. Canada pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 66. Canada pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 67. Europe pet cancer therapeutics market size, by country, 2016 - 2020 (USD Million)
  • TABLE 68. Europe pet cancer therapeutics market size, by country, 2021 - 2027 (USD Million)
  • TABLE 69. Europe pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 70. Europe pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 71. Europe pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 72. Europe pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 73. Europe pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 74. Europe pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 75. Europe pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 76. Europe pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 77. Germany pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 78. Germany pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 79. Germany pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 80. Germany pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 81. Germany pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 82. Germany pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 83. Germany pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 84. Germany pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 85. UK pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 86. UK pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 87. UK pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 88. UK pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 89. UK pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 90. UK pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 91. UK pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 92. UK pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 93. France pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 94. France pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 95. France pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 96. France pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 97. France pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 98. France pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 99. France pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 100. France pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 101. Spain pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 102. Spain pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 103. Spain pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 104. Spain pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 105. Spain pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 106. Spain pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 107. Spain pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 108. Spain pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 109. Italy pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 110. Italy pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 111. Italy pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 112. Italy pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 113. Italy pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 114. Italy pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 115. Italy pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 116. Italy pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 117. Asia Pacific pet cancer therapeutics market size, by country, 2016 - 2020 (USD Million)
  • TABLE 118. Asia Pacific pet cancer therapeutics market size, by country, 2021 - 2027 (USD Million)
  • TABLE 119. Asia Pacific pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 120. Asia Pacific pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 121. Asia Pacific pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 122. Asia Pacific pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 123. Asia Pacific pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 124. Asia Pacific pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 125. Asia Pacific pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 126. Asia Pacific pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 127. China pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 128. China pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 129. China pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 130. China pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 131. China pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 132. China pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 133. China pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 134. China pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 135. India pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 136. India pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 137. India pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 138. India pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 139. India pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 140. India pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 141. India pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 142. India pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 143. Japan pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 144. Japan pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 145. Japan pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 146. Japan pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 147. Japan pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 148. Japan pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 149. Japan pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 150. Japan pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 151. Australia pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 152. Australia pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 153. Australia pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 154. Australia pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 155. Australia pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 156. Australia pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 157. Australia pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 158. Australia pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 159. Latin America pet cancer therapeutics market size, by country, 2016 - 2020 (USD Million)
  • TABLE 160. Latin America pet cancer therapeutics market size, by country, 2021 - 2027 (USD Million)
  • TABLE 161. Latin America pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 162. Latin America pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 163. Latin America pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 164. Latin America pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 165. Latin America pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 166. Latin America pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 167. Latin America pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 168. Latin America pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 169. Brazil pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 170. Brazil pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 171. Brazil pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 172. Brazil pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 173. Brazil pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 174. Brazil pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 175. Brazil pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 176. Brazil pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)
  • TABLE 177. Mexico pet cancer therapeutics market size, by therapy, 2016 - 2020 (USD Million)
  • TABLE 178. Mexico pet cancer therapeutics market size, by therapy, 2021 - 2027 (USD Million)
  • TABLE 179. Mexico pet cancer therapeutics market size, by route of administration, 2016 - 2020 (USD Million)
  • TABLE 180. Mexico pet cancer therapeutics market size, by route of administration, 2021 - 2027 (USD Million)
  • TABLE 181. Mexico pet cancer therapeutics market size, by species, 2016 - 2020 (USD Million)
  • TABLE 182. Mexico pet cancer therapeutics market size, by species, 2021 - 2027 (USD Million)
  • TABLE 183. Mexico pet cancer therapeutics market size, by application, 2016 - 2020 (USD Million)
  • TABLE 184. Mexico pet cancer therapeutics market size, by application, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (supply side analysis)
  • FIG. 2 Data validation
  • FIG. 3 Global pet cancer therapeutics market industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 Global pet cancer therapeutics market size, 2016 - 2027 (USD Million)
  • FIG. 6 Growth potential analysis, by therapy
  • FIG. 7 Growth potential analysis, by route of administration
  • FIG. 8 Growth potential analysis, by species
  • FIG. 9 Growth potential analysis, by application
  • FIG. 10 Porter's analysis
  • FIG. 11 Competitive matrix analysis, 2020
  • FIG. 12 PESTEL analysis
  • FIG. 13 Key segment trends, by therapy
  • FIG. 14 Key segment trends, by route of administration
  • FIG. 15 Key segment trends, by species
  • FIG. 16 Key segment trends, by application
  • FIG. 17 Key regional trends
  • FIG. 18 Competitive dashboard, 2020

The pet cancer therapeutics market is speculated to garner considerable gains by 2027 due to rising pet care expenditure across the globe.

Surging prevalence of cancer among pets has augmented the need for more comprehensive predictive animal models, which has led to an increase in R&D activities in pet cancer therapeutics. Moreover, growing awareness among pet owners regarding pet diseases and therapeutics has propelled industry adoption in recent years.

Notably, industry players have been implementing lucrative initiatives to monetize emerging trends in the market, which has favorably impacted overall business dynamics. For instance, in January 2021, Anivive Lifesciences, a key pharmaceutical company specializing in pet therapeutics, received FDA approval for its novel antineoplastic therapeutic, dubbed the LAVERDIA-CA1. LAVERDIA-CA1 is the first canine-specific small-molecule selective inhibitor of nuclear export (SINE) medication for lymphoma.

The pet cancer therapeutics market has been segmented on the basis of application, therapy, species, route of administration, and region. With respect to therapy, the market has further been categorized into combination therapy, chemotherapy, targeted therapy, and immunotherapy.

In 2020, the targeted therapy sub-segment accounted for a sizable market share with a valuation of more than USD 32 million and is slated to progress at a steady pace over 2021-2027. The versatility of the procedure, coupled with novel advancements in the field of targeted cancer therapy, is estimated to boost segmental growth through the assessment period.

By route of administration, the market has been classified into injection and oral. The pet cancer therapeutics industry share from the oral sub-segment recorded a valuation of nearly USD 80 million in 2020 and is set to observe sturdy expansion over the study timeline. This growth is attributed to the ease of administration of drugs through oral methods.

From the species point of view, the pet cancer therapeutics market has been divided into cats and dogs. The dogs sub-segment held the lion's share of around 95% in the market in 2020 and is projected to expand at a robust pace through the forecast timeframe. Rising prevalence of cancer among dogs and significant developments in the diagnosis and management of canine cancer are likely to foster segmental outlook over the following years.

In terms of application, the pet cancer therapeutics market has been segregated into mammary and squamous cell cancer, lymphoma, melanoma, mast cell cancer, and others. The melanoma sub-segment is anticipated to exceed a valuation of USD 96 million by the end of 2027 on account of mounting incidences of melanoma.

On the regional front, the Latin America pet cancer therapeutics industry was worth over USD 1.8 million in 2020 and is poised to witness optimistic development due to rising awareness among pet owners regarding pet cancer diagnostics and therapeutics.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Pet cancer therapeutics industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Therapy trends
    • 2.1.3 Route of administration trends
    • 2.1.4 Species trends
    • 2.1.5 Applications trends
    • 2.1.6 Regional trends

Chapter 3 Pet Cancer Therapeutics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of pet cancer
      • 3.3.1.2 Growing awareness among pet owners regarding pet diseases
      • 3.3.1.3 Increasing pet care expenditure
      • 3.3.1.4 Technological advancements in pet cancer therapeutics including cancer immunotherapy
      • 3.3.1.5 High medical unmet need and strong potential
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Side effects associated with pet cancer therapeutics
      • 3.3.2.2 Lack of veterinary oncologists
  • 3.4 Growth potential analysis
    • 3.4.1 By therapy
    • 3.4.2 By route of administration
    • 3.4.3 By species
    • 3.4.4 By application
  • 3.5 COVID-19 impact analysis
  • 3.6 Product pipeline analysis
  • 3.7 Regulatory landscape
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2020
    • 3.9.1 Company matrix analysis, 2020
  • 3.10 PESTEL analysis

Chapter 4 Pet Cancer Therapeutics Market, By Therapy

  • 4.1 Key segment trends
  • 4.2 Chemotherapy
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Immunotherapy
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Targeted therapy
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Combination therapy
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Pet Cancer Therapeutics Market, By Route of Administration

  • 5.1 Key segment trends
  • 5.2 Oral
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Injection
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Pet cancer therapeutics Market, By Species

  • 6.1 Key segment trends
  • 6.2 Dogs
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Cats
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Pet Cancer Therapeutics Market, By Application

  • 7.1 Key segment trends
  • 7.2 Lymphoma
    • 7.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 7.3 Mast cell cancer
    • 7.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 7.4 Melanoma
    • 7.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 7.5 Mammary and squamous cell cancer
    • 7.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 7.6 Others
    • 7.6.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 8 Pet Cancer Therapeutics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.2.2 Market size, by therapy, 2016 - 2027 (USD Million)
    • 8.2.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 8.2.4 Market size, by species, 2016 - 2027 (USD Million)
    • 8.2.5 Market size, by application, 2016 - 2027 (USD Million)
    • 8.2.6 U.S.
      • 8.2.6.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.2.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.2.6.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.2.6.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.2.7 Canada
      • 8.2.7.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.2.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.2.7.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.2.7.4 Market size, by application, 2016 - 2027 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.3.2 Market size, by therapy, 2016 - 2027 (USD Million)
    • 8.3.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 8.3.4 Market size, by species, 2016 - 2027 (USD Million)
    • 8.3.5 Market size, by application, 2016 - 2027 (USD Million)
    • 8.3.6 Germany
      • 8.3.6.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.3.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.3.6.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.3.6.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.3.7 UK
      • 8.3.7.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.3.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.3.7.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.3.7.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.3.8 France
      • 8.3.8.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.3.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.3.8.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.3.8.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.3.9 Spain
      • 8.3.9.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.3.9.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.3.9.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.3.9.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.3.10 Italy
      • 8.3.10.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.3.10.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.3.10.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.3.10.4 Market size, by application, 2016 - 2027 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.4.2 Market size, by therapy, 2016 - 2027 (USD Million)
    • 8.4.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 8.4.4 Market size, by species, 2016 - 2027 (USD Million)
    • 8.4.5 Market size, by application, 2016 - 2027 (USD Million)
    • 8.4.6 China
      • 8.4.6.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.4.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.4.6.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.4.6.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.4.7 India
      • 8.4.7.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.4.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.4.7.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.4.7.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.4.8 Japan
      • 8.4.8.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.4.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.4.8.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.4.8.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.4.9 Australia
      • 8.4.9.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.4.9.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.4.9.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.4.9.4 Market size, by application, 2016 - 2027 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 8.5.2 Market size, by therapy, 2016 - 2027 (USD Million)
    • 8.5.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 8.5.4 Market size, by species, 2016 - 2027 (USD Million)
    • 8.5.5 Market size, by application, 2016 - 2027 (USD Million)
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.5.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.5.6.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.5.6.4 Market size, by application, 2016 - 2027 (USD Million)
    • 8.5.7 Mexico
      • 8.5.7.1 Market size, by therapy, 2016 - 2027 (USD Million)
      • 8.5.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 8.5.7.3 Market size, by species, 2016 - 2027 (USD Million)
      • 8.5.7.4 Market size, by application, 2016 - 2027 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Competitive dashboard, 2020
  • 9.2 Zoetis, Inc.
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Elanco Animal Health
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Merial, Inc. (Boehringer Ingelheim International GmbH)
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Anivive Lifesciences, Inc.
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 AB Science
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Qbiotics
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 NovaVive, Inc.
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 ELIAS Animal Health
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
Back to Top
전화 문의
F A Q